CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

82 filings reported holding CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share as of Q4 2024.
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46.7M shares of 164M outstanding shares and own 28.47% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (7.31M shares), BVF INC/IL (5.23M shares), VANGUARD GROUP INC (5.16M shares), Prosight Management, LP (3.91M shares), MILLENNIUM MANAGEMENT LLC (3.22M shares), ACADIAN ASSET MANAGEMENT LLC (3.14M shares), Point72 Asset Management, L.P. (2.65M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (1.55M shares), Schonfeld Strategic Advisors LLC (1.38M shares), and RENAISSANCE TECHNOLOGIES LLC (1.35M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.